LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.75 | 84.90 | 2258 | 8621 | 0.2619 | 0.6359 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.75 | 84.90 | 2280 | 8621 | 0.2645 | 0.6382 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.45 | 84.90 | 1790 | 8254 | 0.2168 | 0.5867 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.45 | 84.90 | 1811 | 8254 | 0.2194 | 0.5895 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.45 | 84.90 | 2298 | 8254 | 0.2784 | 0.6479 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.45 | 84.90 | 2334 | 8254 | 0.2827 | 0.6518 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 86.16 | 84.90 | 1852 | 8141 | 0.2275 | 0.5972 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 86.16 | 84.90 | 1881 | 8141 | 0.2310 | 0.6009 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 86.16 | 84.90 | 2352 | 8141 | 0.2889 | 0.6562 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 86.16 | 84.90 | 2374 | 8141 | 0.2916 | 0.6586 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 87.86 | 84.90 | 1895 | 7680 | 0.2467 | 0.6126 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 87.86 | 84.90 | 1924 | 7680 | 0.2505 | 0.6163 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 87.86 | 84.90 | 2413 | 7680 | 0.3142 | 0.6737 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 87.86 | 84.90 | 2435 | 7680 | 0.3170 | 0.6760 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 89.57 | 84.90 | 1915 | 7494 | 0.2555 | 0.6194 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 89.57 | 84.90 | 1950 | 7494 | 0.2602 | 0.6240 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 89.57 | 84.90 | 2459 | 7494 | 0.3281 | 0.6833 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 89.57 | 84.90 | 2478 | 7494 | 0.3306 | 0.6853 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 91.27 | 84.90 | 1944 | 7420 | 0.2620 | 0.6249 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 91.27 | 84.90 | 1995 | 7420 | 0.2689 | 0.6315 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 91.27 | 84.90 | 2525 | 7420 | 0.3403 | 0.6922 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 91.27 | 84.90 | 2540 | 7420 | 0.3423 | 0.6937 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 92.98 | 84.90 | 1819 | 7257 | 0.2506 | 0.6121 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 92.98 | 84.90 | 2020 | 7257 | 0.2783 | 0.6386 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 92.98 | 84.90 | 2595 | 7257 | 0.3576 | 0.7039 | MN20160318_Q02 | I05 |